Seelos Therapeutics Inc (SEEL)
0.305
+0.01
(+1.90%)
USD |
NASDAQ |
May 02, 11:51
Seelos Therapeutics 1 Year Total Returns (Daily): -98.55% for May 1, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 01, 2024 | -98.55% |
April 30, 2024 | -98.65% |
April 29, 2024 | -98.65% |
April 26, 2024 | -98.53% |
April 25, 2024 | -98.58% |
April 24, 2024 | -98.57% |
April 23, 2024 | -98.40% |
April 22, 2024 | -98.41% |
April 19, 2024 | -98.61% |
April 18, 2024 | -98.57% |
April 17, 2024 | -98.57% |
April 16, 2024 | -98.35% |
April 15, 2024 | -98.14% |
April 12, 2024 | -98.17% |
April 11, 2024 | -98.22% |
April 10, 2024 | -97.81% |
April 09, 2024 | -97.89% |
April 08, 2024 | -97.81% |
April 05, 2024 | -97.63% |
April 04, 2024 | -97.61% |
April 03, 2024 | -97.47% |
April 02, 2024 | -97.30% |
April 01, 2024 | -97.18% |
March 28, 2024 | -97.19% |
March 27, 2024 | -96.88% |
Date | Value |
---|---|
March 26, 2024 | -97.41% |
March 25, 2024 | -97.58% |
March 22, 2024 | -97.51% |
March 21, 2024 | -97.73% |
March 20, 2024 | -97.35% |
March 19, 2024 | -96.73% |
March 18, 2024 | -95.38% |
March 15, 2024 | -94.68% |
March 14, 2024 | -94.94% |
March 13, 2024 | -94.45% |
March 12, 2024 | -94.29% |
March 11, 2024 | -93.99% |
March 08, 2024 | -93.50% |
March 07, 2024 | -93.89% |
March 06, 2024 | -94.34% |
March 05, 2024 | -95.12% |
March 04, 2024 | -94.37% |
March 01, 2024 | -94.32% |
February 29, 2024 | -94.56% |
February 28, 2024 | -95.11% |
February 27, 2024 | -95.41% |
February 26, 2024 | -95.17% |
February 23, 2024 | -95.26% |
February 22, 2024 | -96.17% |
February 21, 2024 | -96.35% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-98.65%
Minimum
Apr 30 2024
1.21K%
Maximum
Apr 07 2021
13.32%
Average
-51.30%
Median
Sep 04 2020
1 Year Total Returns (Daily) Benchmarks
180 Life Sciences Corp | -90.48% |
Acurx Pharmaceuticals Inc | -27.46% |
NovaBay Pharmaceuticals Inc | -91.85% |
Palatin Technologies Inc | -18.34% |
iBio Inc | -91.51% |